Product Information
EPINEPHRINE 0.15 MG AUTO-INJCT is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $117.9660 per EA under NDC 00115169530. Its NADAC has been published 215 times since Aug 24, 2022.
FDA first approved this application on May 30, 2003. Its Orange Book therapeutic-equivalence code is BX.
Strength
.15 mg/.15mL
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115169530
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
EPINEPHRINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020800FDA Approved
5/30/2003
TE Code
BX
On Market Since
4/1/2010
Pharmacological Classes
Price Statistics
The NADAC for EPINEPHRINE 0.15 MG AUTO-INJCT has been published 215 times since Aug 24, 2022, and over the history we have for it it has declined 13.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $117.9660 per EA |
|---|---|
| All-time high | $136.9870 (Sep 14, 2022) |
| All-time low | $91.1424 (Nov 20, 2024) |
| 52-week high | $129.8800 |
| 52-week low | $117.9660 |
| Median price | $119.4009 |
| Average price | $118.3153 |
| Largest weekly change | -18.0% (Nov 20, 2024) |
| Weeks tracked | 215 |
| Tracking since | Aug 24, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
epinephrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Catecholamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPINEPHRINE 0.15 MG AUTO-INJCT?
The current National Average Drug Acquisition Cost (NADAC) for EPINEPHRINE 0.15 MG AUTO-INJCT, manufactured by Amneal Pharmaceuticals of New York LLC, is $117.9660 per EA (NDC 00115169530), effective Sep 30, 2026.
How has the price of EPINEPHRINE 0.15 MG AUTO-INJCT changed over time?
Over the history we have for it, the NADAC for EPINEPHRINE 0.15 MG AUTO-INJCT has declined 13.9%. It has been tracked across 215 weekly CMS publications since Aug 24, 2022.
What are the highest and lowest recorded NADAC prices for EPINEPHRINE 0.15 MG AUTO-INJCT?
Since Aug 24, 2022, the NADAC for EPINEPHRINE 0.15 MG AUTO-INJCT has ranged from a low of $91.1424 (Nov 20, 2024) to a high of $136.9870 (Sep 14, 2022), with a median of $119.4009 per EA.
Are there cheaper alternatives to EPINEPHRINE 0.15 MG AUTO-INJCT?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EPINEPHRINE 0.15 MG AUTO-INJCT in a comparable dosage form, but none are currently priced below it.
Who manufactures EPINEPHRINE 0.15 MG AUTO-INJCT?
EPINEPHRINE 0.15 MG AUTO-INJCT (NDC 00115169530) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.